Sinorhizobium sp. For producing glucogalactan and application of sinorhizobium sp.

Through screening and identification of Sinorhizobium sp. ACT002, high-yield galactan production was achieved, solving the problem of not only single sugar production types and low yields of Rhizobium Chinese osmanthus, and demonstrating its healing in skin wounds Effective application.

CN118909839APending Publication Date: 2024-11-08NANJING UNIV OF SCI & TECH
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410983050.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-22
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

In the prior art, Rhizobia phyllum Chinese is difficult to produce glucogalactan composed of glucose and galactose disaccharide units, and the separation and purification process is complex, the recovery rate and yield are low, making it difficult to achieve large-scale application.

Method used

A strain of Sinorhizobium sp. ACT002, a strain of Rhizobium Chinese, was screened and identified, which was able to produce glucosyl galactan composed of glucosyl units under specific culture conditions, and obtained high yield glucosyl galactan by fermentation and purification steps. Lactoglycan, yielding up to 16.5 g/L, and its structure is optimized by acetyl and pyruvate.

Benefits of technology

The production of glulocalis with high yield was achieved, overcoming the problem of not only single sugar production types and low yields of traditional Chinese rhizobia glutinosa, and demonstrating the application potential of glulocalis in promoting skin wound healing.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118909839A_ABST
    Figure CN118909839A_ABST
Patent Text Reader

Abstract

The invention discloses a sinorhizobium sp. For producing glucogalactan and application of the sinorhizobium sp. The preservation number of the rhizobium sinensis ACT002 is CCTCC NO: M 2024038, the weight-average molecular weight of glucogalactan produced by the rhizobium sinensis ACT002 is 1.0 * 10 < 6 >-3.8 * 10 < 7 > Da, the glucogalactan is formed by alternately connecting beta-D-glucose and alpha-D-galactose through 1-3 glucosidic bonds, the molar ratio of the glucose to the galactose is 1: 1, the glucose and the galactose are modified by acetyl and pyruvoyl ketal groups, the molar ratio of the acetyl and the pyruvoyl ketal groups is 1: 10, and the beta-1, 2-D-glucose and the alpha-D-galactose are modified by the 1-3 glucosidic bonds. The C6 site of alpha-1, 3-glucose is modified by acetyl, the degree of substitution is 10%, the C4 and C6 sites of alpha-1, 3-galactose are modified by pyruvic acid groups to form pyruvoyl ketal groups, and the degree of substitution is 100%. The glucogalactan can effectively promote the healing speed of mouse skin wounds, and has great application potential in skin trauma repair.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of microorganisms and relates to a Sinorhizobium strain for producing glucogalactan and application thereof. Background Art

[0002] Glucogalactan, also known as galactoglucan, is a type of macromolecular linear or branched polysaccharide formed by the polymerization of glucose and galactose. Some of them also contain monosaccharides such as mannose, arabinose, xylose, fructose, and glucuronic acid. In addition, some glucogalactans contain modification groups such as pyruvyl, acetyl, and succinyl (succinyl). At present, dozens of glucogalactans have been isolated and identified from plants (such as pumpkin and kumquat), large fungi (such as Ganoderma lucidum and Poria cocos), fungi (such as Alternaria alternata and Fusarium) and bacteria (such as Lactobacillus pentosus and Rhizobium). The molar ratio of glucose to galactose is different, and the other monosaccharide components and modification groups they contain are different. Studies have found that glucogalactan has many important activities such as hygroscopicity, anti-oxidation, maintaining the homeostasis of intestinal microbial flora, lowering blood sugar, regulating immunity, and anti-tumor, and has great application potential in the fields of food, health products, cosmetics, and medicine. However, the current separation and purification process of glucogalactan is complex, the recovery rate and yield are low, and it is difficult to apply it on a large scale. Therefore, it is of great significance to find microorganisms with high glucogalactan production potential and increase polysaccharide production for the production and application of glucogalactan.

[0003] Rhizobia play a central role in the symbiotic nitrogen fixation of legumes. Studies have found that most of the exopolysaccharides secreted by Rhizobiaceae bacteria are glucogalactans (Janczarek M. International Journal of Molecular Sciences, 2011, 12, 7898-7933; Acosta-Jurado S, et al. International Journal of Molecular Sciences, 2021, 22, 6233.). Therefore, rhizobia have become potential microbial factories for the production of glucogalactans. For example, Sinorhizobium meliloti can synthesize glucogalactans (EPSII) composed of repeating units of glucose and galactose disaccharides (Mendrygal KE, et al. Journal of Bacteriology, 2008, 190 (10): 3456-3466). However, in general, Sinorhizobium meliloti mainly synthesizes succinoglycan (EPSI), which is composed of octasaccharide repeating units, and the molar ratio of glucose to galactose is 7: 1. During the synthesis of EPSI, galactosyltransferase ExoY (encoding gene exoY) connects galactoside to lipid carriers, which is the first step in EPSI synthesis, while the global regulatory protein MucR (encoding gene mucR) promotes the synthesis of EPSI and inhibits the synthesis of EPSII (Rinaudi et al. FEMS Microbiology Letters, 2010, 302: 15-21). Therefore, it is generally difficult to obtain a higher yield of glucosylgalactan composed of glucose and galactose disaccharide units. Although it has been reported in the literature that knocking out exoY can achieve the extracellular secretion of EPSII by Sinorhizobium meliloti (Mendrygal KE, et al. Journal of Bacteriology, 2000, 182: 599-606), it is still impossible to achieve a large amount of extracellular EPSII synthesis.

[0004] Screening specific strains can help obtain higher yields of glucogalactan. For example, Moretto et al. screened a rhizobium strain Rhizobium sp. LBMP-C04, whose extracellular polysaccharide yield reached 6.63 g / L, which is a relatively high level reported in public. However, its monosaccharide composition is glucose: galactose: mannose: glucuronic acid: rhamnose = 54.17: 38.99: 2.68: 3.57: 0.60 (International Journal of Biological Macromolecules, 2015, 81: 291-298), which is different from the glucogalactan with equal molar ratios of glucose and galactose units. In summary, obtaining specific rhizobia with high glucogalactan yield through strain screening is of great significance for the large-scale production and application of glucogalactan. Summary of the invention

[0005] One of the purposes of the present invention is to provide a strain of Sinorhizobium sp. ACT002. The strain was identified as Sinorhizobium sp. by molecular biology, and was deposited in the China Center for Type Culture Collection (CCTCC) on January 9, 2024, with a deposit number of CCTCC NO: M 2024038, and the deposit address is Wuhan University, Wuhan, China.

[0006] The second object of the present invention is to provide a method for culturing the above-mentioned Sinorhizobium ACT002, the specific steps of which are as follows:

[0007] The seed liquid of Sinorhizobium rhizobium ACT002 is inoculated into a fermentation medium and cultured under shaking at 28-35° C. The fermentation medium comprises: 15-60 g / L sucrose, 0.5-2.5 g / L yeast extract, 1-3 g / L NaNO3, 0.5-1 g / L KCl, 0.5-1 g / L MgSO4, 0.01-0.05 g / L FeSO4, 1-5 g / L alkaline salt, and pH=6.5-7.5.

[0008] Preferably, the inoculation amount of the Sinorhizobium ACT002 seed solution is 0.5% to 5%, and the alkaline salt is Na2CO3, NaHCO3 or Tris.

[0009] The third object of the present invention is to provide a glucogalactan, which is a linear polysaccharide formed by alternating β-D-glucose (β-D-Glc) and α-D-galactose (α-D-Gal) through 1→3 glycosidic bonds, wherein the molar ratio of glucose to galactose is 1:1, and the glucogalactan contains acetyl and pyruvyl modifications in a molar ratio of 1:10, and has a weight average molecular weight of 1.0×10 6 ~3.8×10 7 Da, the structural formula is:

[0010]

[0011] , wherein n=2500-95000, the C6 position of β-1,3-glucose is modified by an acetyl group with a substitution degree of 10%, and the C4 and C6 positions of α-1,3-galactose are modified by pyruvic acid groups to form a pyruvyl ketal group with a substitution degree of 100%.

[0012] A fourth object of the present invention is to provide a method for producing the above-mentioned glucogalactan, comprising the following steps:

[0013] (1) Fermentation of Sinorhizobium rhizobium ACT002:

[0014] Inoculate the seed liquid of Sinorhizobium rhizobium ACT002 into a fermentation medium, and culture under shaking at 28-35° C. The fermentation medium comprises: 15-60 g / L sucrose, 0.5-2.5 g / L yeast extract, 1-3 g / L NaNO3, 0.5-1 g / L KCl, 0.5-1 g / L MgSO4, 0.01-0.05 g / L FeSO4, 1-5 g / L alkaline salt, and pH=6.5-7.5;

[0015] (2) Separation of crude glucosamine:

[0016] The fermentation liquid obtained in step (1) is centrifuged, the precipitate is discarded and the supernatant is collected, anhydrous ethanol is added to the supernatant, and the polysaccharide is precipitated by shaking, and the precipitate is recovered by filtration and dried to obtain a crude glucogalactan.

[0017] Preferably, in step (1), the shaking culture time is 36 to 72 hours.

[0018] Preferably, in step (2), the centrifugal speed is 5000g, the centrifugal time is 30min, the amount of anhydrous ethanol added is 2 to 3 times the volume of the supernatant, and the drying temperature is 50 to 75°C.

[0019] A fifth object of the present invention is to provide a method for purifying the above-mentioned glucogalactan, comprising the following steps:

[0020] (1) Dissolve the crude glucogalactan in water, centrifuge, discard the precipitate and collect the supernatant;

[0021] (2) adding an equal volume of chloroform / n-butanol solvent to the supernatant obtained in step (1), wherein the volume ratio of chloroform to n-butanol is 4:1, shaking, centrifuging, and recovering the aqueous phase;

[0022] (3) Repeat step (2) until the protein layer at the interface between the aqueous phase and the organic phase disappears, add anhydrous ethanol to the recovered aqueous phase, shake to precipitate the polysaccharide, filter and recover the precipitate, and dry to obtain pure glucogalactan.

[0023] Preferably, in step (1) or (2), the centrifugal speed is 5000g and the centrifugal time is 30min.

[0024] Preferably, in step (3), the amount of anhydrous ethanol added is 2 to 3 times the volume of the aqueous phase, and the drying temperature is 50 to 75°C.

[0025] The sixth object of the present invention is to provide the use of the above-mentioned glucogalactan in the preparation of a drug for promoting skin wound healing.

[0026] Compared with the prior art, the present invention has the following advantages:

[0027] (1) The Chinese rhizobium ACT002 screened and obtained in the present invention can synthesize a single glucogalactan composed of glucose and galactose disaccharide units, overcoming the shortcomings of the traditional Chinese rhizobium of Melilotifolia that the sugar types produced are not single and the glucogalactan (EPSII) production is low. In addition, it has excellent extracellular polysaccharide production ability, and the production of glucogalactan crude sugar can reach 16.5 g / L, which is significantly higher than the reported level of extracellular polysaccharide production by rhizobia.

[0028] (2) The glucogalactan of the present invention can effectively promote skin wound healing and has broad application prospects in the medical field. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Figure 1 This is the colony morphology of Sinorhizobium rhizobium ACT002 on solid culture medium and the microscopic image of the bacteria after being stained with methylene blue;

[0030] Figure 2 It is the phylogenetic tree constructed by maximum likelihood method based on 16S rDNA nucleic acid sequence and the position of Sinorhizobium ACT002 in it;

[0031] Figure 3 is the one-dimensional and two-dimensional NMR spectra of glucogalactan;

[0032] Figure 4 is the gel permeation chromatogram of glucogalactan;

[0033] Figure 5 is the healing of mouse wounds over time;

[0034] Figure 6 This is the wound healing rate curve of mice. DETAILED DESCRIPTION

[0035] The present invention is further described in detail below in conjunction with specific embodiments and accompanying drawings.

[0036] Example 1

[0037] Isolation and identification of Sinorhizobium rhizobium ACT002:

[0038] 1. Strain Isolation

[0039] The Sinorhizobium ACT002 of the present invention is isolated from the soil of the original forest in Enshi City, Hubei Province. The specific isolation method is:

[0040] (1) Strain screening: Weigh 1 g of the collected soil sample and add it to 20 mL of sterile saline, then shake and incubate at 30°C for 15 min. Then, dilute the soil suspension to 100 to 10,000 times with sterile saline, apply 100 μL of each dilution to a 9 mm culture dish containing Czapek medium, and incubate at 30°C for 2 days until colonies are formed.

[0041] (2) Strain purification: After the colonies grow, a single colony with a smooth and mucous surface is selected according to the colony morphology and streaked on a new Czapek solid medium. The culture is then cultured at 30°C. After the colonies grow, a single colony is selected and streaked again. This process is repeated 10 times until all the colonies grown on the culture dish are of a single morphology.

[0042] (3) Preliminary verification: Pick a ring of sticky single colonies and inoculate them into a 250 mL shake flask containing 50 mL of Czapek liquid medium. Culture at 200 rpm and 30°C for 2 days. If the fermentation liquid becomes sticky, identify whether the extracellular fermentation product is a polysaccharide. The strain whose fermentation product is a polysaccharide after identification is named ACT002.

[0043] 2. Strain Identification

[0044] (1) Morphological characteristics: After culturing on Czapek agar solid medium at 30°C for 2 days, the colonies were round, light yellow, opaque, shiny, sticky, and difficult to pick up. The strain was short rod-shaped and small in size, 0.3-0.6 μm × 0.8-2 μm. Figure 1 shown.

[0045] (2) Molecular biological analysis: PCR amplification was performed using the genomic DNA of strain ACT002 as a template and the universal primers (27F, 1492R) for PCR amplification of the 16S rDNA gene as primers. The sequence was determined to obtain an effective sequence length of 1269 bp. The 16S rDNA gene sequence of the strain is shown in SEQ ID No. 1.

[0046] The 16S rDNA gene sequence of the strain was compared with the sequences in the GenBank database. The results showed that the strain ACT002 had a high similarity with the microorganisms of the genus Sinorhizobium and with the model strain of Ensifersesbaniae CCBAU 65729. T) has the highest similarity, see the results Figure 2 .

[0047] Based on morphological and molecular biological analysis, the strain ACT002 was identified as a bacterium of the genus Sinorhizobium (synonyms of the genus: Ensifer), and was named Sinorhizobium ACT002. The strain was deposited in the China Center for Type Culture Collection (CCTCC) on January 9, 2024, with the deposit number CCTCC NO: M 2024038, and the deposit address is Wuhan University, Wuhan, China.

[0048] Example 2

[0049] Exopolysaccharide production by fermentation of Sinorhizobium rhizobium ACT002:

[0050] (1) Pick a single colony of Sinorhizobium rhizobium ACT002 grown on Czapek agar medium and inoculate it into a 250 mL shake flask containing 50 mL of seed medium. Shake and culture at 28°C for 18 h to obtain seed solution. The composition of the seed medium is: sucrose 20 g / L, yeast extract 2.5 g / L, NaNO3 3 g / L, KCl 1 g / L, MgSO4 1 g / L, FeSO4 0.05 g / L, Tris 1 g / L. Use HCl to adjust the pH of the seed solution to 7.0.

[0051] (2) The seed solution containing Sinorhizobium ACT002 was inoculated into a 500 mL shake flask containing a fermentation medium at a 1% (v / v) inoculation rate, and the culture was shaken at 30°C for 60 h to obtain a fermentation broth. The fermentation medium composition was: sucrose 50 g / L, yeast extract 0.5 g / L, NaNO3 1 g / L, KCl 0.5 g / L, MgSO4 0.5 g / L, FeSO4 0.05 g / L, Na2CO3 5 g / L. The pH of the medium was adjusted to 6.5 using H2SO4.

[0052] (3) The fermentation broth was centrifuged at 5000 g for 30 min, and the precipitate was discarded to recover the supernatant. Then, anhydrous ethanol was added in an amount 3 times the volume of the supernatant, and the polysaccharide was precipitated by vigorous shaking, and the precipitate was filtered and recovered. Subsequently, the precipitate was placed in a 75° C. oven and dried to constant weight, thereby obtaining a crude glucogalactan with a yield of 11.4 g / L.

[0053] Example 3

[0054] Exopolysaccharide production by fermentation of Sinorhizobium rhizobium ACT002:

[0055] (1) Pick a single colony of Sinorhizobium rhizobium ACT002 grown on Czapek agar medium and inoculate it into a 250 mL shake flask containing 50 mL of seed medium. Shake and culture at 35°C for 24 h to obtain seed solution. The composition of the seed medium is sucrose 20 g / L, yeast extract 2.5 g / L, NaNO3 3 g / L, KCl 1 g / L, MgSO4 1 g / L, FeSO4 0.05 g / L, Tris 1 g / L. Use HCl to adjust the pH of the seed solution to 6.5.

[0056] (2) The seed solution containing Sinorhizobium ACT002 was inoculated into a 500 mL shake flask containing a fermentation medium at a 5% (v / v) inoculation rate, and the culture was shaken at 35°C for 72 h to obtain a fermentation broth. The fermentation medium consisted of 60 g / L sucrose, 1.0 g / L yeast extract, 1 g / L NaNO3, 0.5 g / L KCl, 0.5 g / L MgSO4, 0.05 g / L FeSO4, and 5 g / L Na2CO3. The pH of the medium was adjusted to 7.5 using H2SO4.

[0057] (3) The fermentation liquid was centrifuged at 5000 g for 30 min, and the precipitate was discarded to recover the supernatant. Then, anhydrous ethanol was added in an amount 3 times the volume of the supernatant, and the polysaccharide was precipitated by vigorous shaking, and the precipitate was filtered and recovered. Subsequently, the precipitate was placed in a 75° C. oven and dried to constant weight, thereby obtaining a crude glucogalactan with a yield of 14.8 g / L.

[0058] Example 4

[0059] Purification of exopolysaccharides produced by fermentation of Sinorhizobium rhizobium ACT002:

[0060] (1) Prepare seed solution according to the method described in Example 3.

[0061] (2) Inoculate the seed solution of Sinorhizobium rhizobium ACT002 into a 250 mL shake flask containing a fermentation medium at a 5% (v / v) inoculation rate, and culture at 35°C with shaking for 72 h to obtain a fermentation broth. The fermentation medium composition is: sucrose 60 g / L, yeast extract 2.5 g / L, NaNO3 3 g / L, KCl 0.5 g / L, MgSO4 0.5 g / L, FeSO4 0.05 g / L, Na2CO3 1 g / L, NaHCO3 1 g / L, Tris 1 g / L. Use H2SO4 to adjust the pH of the medium to 7.5.

[0062] (3) The fermentation broth was centrifuged at 5000 g for 30 min, and the precipitate was discarded to recover the supernatant. Then, anhydrous ethanol was added in an amount 2.5 times the volume of the supernatant, and the polysaccharide was precipitated by vigorous shaking, and the precipitate was filtered and recovered. Subsequently, the precipitate was placed in a 75° C. oven and dried to constant weight, thereby obtaining a crude glucogalactan with a yield of 16.5 g / L.

[0063] (4) Dissolve the crude glucosamine in deionized water to a final polysaccharide concentration of 5 g / L, then centrifuge at 5000 g for 30 min, discard the insoluble matter and recover the supernatant. Add an equal volume of chloroform / n-butanol solvent to the supernatant, where the volume ratio of chloroform to n-butanol is 4:1, shake vigorously, then centrifuge at 5000 g for 30 min, and recover the aqueous phase. Repeat this step 8 times until the protein layer disappears, and then centrifuge to recover the aqueous phase. Add 3 times the volume of anhydrous ethanol to the aqueous phase, shake to precipitate the polysaccharide, and filter to recover the precipitate. Then, place the precipitate in a 75°C oven and dry to constant weight to obtain pure glucosamine. The recovery rate of pure glucosamine is 56.2% based on crude sugar.

[0064] Example 5

[0065] Structural analysis of ACT002-produced glucosamine:

[0066] (1) The chemical structure of glucogalactan was analyzed using one-dimensional and two-dimensional nuclear magnetic resonance technology (1D / 2D NMR).

[0067] The pure glucogalactan obtained in Example 4 was used as the analysis material. Since glucogalactan has a high viscosity and a weak signal is obtained in nuclear magnetic resonance, the molecular weight of glucogalactan was first reduced by acid hydrolysis technology. The pure glucogalactan obtained in Example 4 was dissolved in pure water to form a 5 g / L polysaccharide solution, concentrated trifluoroacetic acid (TFA) was added to a final concentration of TFA of 1 mol / L, and then the solution was heated in a 60°C water bath for 10 min, and then the pH was adjusted to neutral with a 4 mol / L NaOH solution. Subsequently, an equal volume of acetonitrile was added to precipitate the polysaccharide, the precipitate was collected by centrifugation at 5000g for 20 min and dried in a 65°C oven to constant weight, and 100 mg of glucogalactan with reduced molecular weight was obtained.

[0068] Dissolve the dried glucosamine with 1 mL of heavy water (D2O) containing the internal standard TMSP, and then freeze-dry to obtain heavy water-substituted glucosamine. Dissolve the freeze-dried polysaccharide with 1 mL of heavy water (D2O) containing the internal standard TMSP again for NMR analysis. 1 H. 13 C, DEPT-135, COSY, NOESY, HSQC analysis and spectrum acquisition, the results are shown in Figure 3 .from 1 H spectrum ( Figure 3 As can be seen in a), the chemical shifts of 5.45 ppm (A) and 4.71 ppm (B) correspond to the proton peaks on the anomeric carbons of α-D-Gal and β-D-Glc, respectively. 13 C spectrum ( Figure 3b) correspond to two signal peaks at 102.36 ppm and 107.60 ppm, which is consistent with DEPT-135 ( Figure 3 c) and HSQC( Figure 3 f) are consistent with A1 and B1. In addition, from COSY ( Figure 3 d) HMBC( Figure 3 e) and HSQC( Figure 3 f) It can be seen that α-D-Gal and β-D-Glc are both connected alternately through 1→3, and the corresponding connection site signal peak chemical shifts are 4.16 / 79.98ppm and 3.68 / 84.13ppm, respectively. Figure 3 f are marked as A3 and B3 respectively. 1 H. 13 The C signal peak and C=O signal peak are located at 2.15ppm, 23.23ppm and 176.94ppm respectively. Figure 3 f, B'8). Pyruvic acid reacts with C4 and C6 of α-D-Gal through COC to form a cyclic pyruvyl ketal group (pyruvyl ketal-, CH3C(OO)COOH), methyl 1 H. 13 The C signal peaks, ketal signal peaks, and C=O signal peaks are located at 1.47ppm, 28.02ppm, 103.60ppm, and 178.81ppm, respectively. Figure 3 f, A9). Figure 3 In e, the typical signal peaks generated by protons through the NOE effect are marked with boxes, and their coupling relationship is Figure 3 In g, it is marked by a double-headed arrow. Figure 3 In e HSQC, the attribution of each signal peak of galactose and glucose C1~C6 is marked as A1~A6 and B1~B6 respectively. The signal peak of acetyl-modified glucose is very weak due to its low content, and the corresponding attribution is marked as B'1, B'5, and B'8.

[0069] because 1 The peak area of ​​the H signal can be used for quantification. Figure 3It can be concluded that the signal peak area ratios of Gal anomeric carbon H (5.45ppm), acetyl modified Glc anomeric carbon H (4.83ppm), unmodified Glc anomeric carbon H (4.71ppm), acetyl methyl H (2.15ppm) and acetone acetal methyl H (1.47ppm) are 1.00:0.09:0.94:0.30:3.10 respectively. It can be seen that the molar ratio of Gal to Glc is 1.00:1.03, the molar ratio of anomeric carbon H and methyl H is approximately 1:3, the ratio of glucose residues not modified by acetyl and glucose residues modified by acetyl is 90% and 10% respectively, and the molar ratio of acetyl and acetone acetal is 1:10. The results show that the glucogalactan prepared in this embodiment is a linear polysaccharide formed by alternating 1→3 glycosidic bonds between α-D-Gal and β-D-Glc, and the molar ratio of acetyl and acetone acetal is 1:10. The difference between this structure and the chemical structure of EPSII produced by Sinorhizobium meliloti is that the molar ratio of glucose residues, galactose residues, acetyl groups and pyruvyl ketal groups in EPSII is approximately 1:1:1:1 (Her GR et al.Carbohydrate Research, 1990, 198:305-312; Acosta-Jurado S, et al.International Journal of Molecular Sciences, 2021, 22, 6233), and the acetyl modification ratio of glucogalactan obtained in this embodiment is only 10%, which is significantly lower than EPSII. The possible reason is that ACT002 has a closer evolutionary relationship with Sesbania truncatula and a more distant relationship with Sinorhizobium meliloti, and there are differences in the intracellular polysaccharide synthesis pathways. However, there is no public report on the chemical structure of extracellular glucogalactan from Sesbania truncatula.

[0070] Example 6

[0071] Molecular weight determination of ACT002-produced glucosamine:

[0072] Weigh 1.00 g of the purified glucogalactan prepared in Example 4, dissolve it in 1 L of deionized water to prepare a 1.00 g / L polysaccharide solution, then filter it with a 0.45 μm filter membrane, and take the filtrate to determine the molecular weight of the polysaccharide. Use a Waters GPC system, a chromatographic column of Tosoh TSKgel SuperMultiporePW-H (6×150 mm, 8 μm), a column temperature of 35°C, a mobile phase of pure water, a flow rate of 0.5 mL / min, and a differential refractive index detector. See the elution chromatogram Figure 4 Calculated by the calibration curve, the weight average molecular weight of glucogalactan is 3.76×10 7 Da.

[0073] The crude glucogalactan prepared in Example 3 was used to prepare pure glucogalactan according to the method of Example 4. The molecular weight was determined by the same method as above. The weight average molecular weight of glucogalactan was calculated by the calibration curve and was 3.12×10 7 Da.

[0074] Example 7

[0075] ACT002 produces glucosamine to promote skin wound healing experiment:

[0076] (1) Weigh 1.00 g of the purified glucogalactan prepared in Example 4, dissolve it in 0.05 L of deionized water to prepare a 20 g / L polysaccharide solution, then centrifuge it at 5000 g for 30 min, and recover the supernatant. Then, sterilize the polysaccharide solution with wet heat at 121° C. for 20 min, and place it at room temperature for later use.

[0077] (2) Eight-week-old C57BL / 6 female mice (weight 20±2 g) were selected, their backs were shaved, and a 10 mm diameter wound was made on the back of each mouse using a hole punch ( Figure 5 Then, 200 μL / mouse of 2% glucosamine solution sterilized by moist heat was applied to the wound surface and fixed with a transparent dressing (model 1626W, produced by 3M Company). Sterile saline was used as the control group and treated in the same way.

[0078] (3) Record the wound recovery status on the 1st, 3rd, 5th, 7th and 9th days. Calculate the healing percentage based on the wound area. The calculation formula is: healing percentage = A n / A0×100%. Among them, A n is the wound area on day n after treatment (mm 2 ), A0 is the initial wound area (mm 2 ).

[0079] The results showed that after 3 days of treatment with glucosamine, the healing speed of mouse skin wounds was significantly accelerated. On the 5th day after treatment, the wound healing percentage of the 2% glucosamine group reached 71.79%, which was significantly higher than that of the control group (28.64%, P = 0.008), indicating that glucosamine can effectively promote skin wound healing ( Figure 6 ). There is no public report on the promotion of wound healing by glucogalactan with equal molar ratio of glucose and galactose. The present invention broadens the application field of glucogalactan.

Claims

1. Sinorhizobium rhizobium Sinorhizobium sp.) ACT002, the deposit number is CCTCC NO: M 2024038.

2. The method for culturing Sinorhizobium rhizobium ACT002 according to claim 1, characterized in that: The specific steps are as follows: The seed liquid of Sinorhizobium rhizobium ACT002 is inoculated into a fermentation medium and cultured under shaking at 28-35°C. The fermentation medium comprises: 15-60 g / L sucrose, 0.5-2.5 g / L yeast extract, 1-3 g / L NaNO3, 0.5-1 g / L KCl, 0.5-1 g / L MgSO4, 0.01-0.05 g / L FeSO4, 1-5 g / L alkaline salt, and pH=6.5-7.

5.

3. The culture method according to claim 2, characterized in that The inoculation amount of Sinorhizobium ACT002 seed solution is 0.5%~5%, and the alkaline salt is Na2CO3, NaHCO3 or Tris.

4. A glucogalactan, characterized in that: It is a linear polysaccharide composed of β-D-glucose and α-D-galactose alternately connected by 1→3 glycosidic bonds, with a molar ratio of glucose to galactose of 1:1, and contains acetyl and acetonyl ketal modifications with a molar ratio of 1:

10. The weight-average molecular weight is 1.0×10 6 ~ 3.8×10 7 Da, the structural formula is: , where n = 2500 ~ 95000, the C6 position of β-1,3-glucose is modified by acetyl group with a substitution degree of 10%, and the C4 and C6 positions of α-1,3-galactose are modified by pyruvic acid groups to form pyruvyl ketal groups with a substitution degree of 100%.

5. The method for producing glucogalactan according to claim 4, characterized in that: The following steps are involved: (1) Fermentation of Sinorhizobium rhizobium ACT002: The seed solution of Sinorhizobium ACT002 described in claim 1 is inoculated into a fermentation medium, and cultured under shaking at 28-35°C, wherein the fermentation medium comprises: 15-60 g / L sucrose, 0.5-2.5 g / L yeast extract, 1-3 g / L NaNO3, 0.5-1 g / L KCl, 0.5-1 g / L MgSO4, 0.01-0.05 g / L FeSO4, 1-5 g / L alkaline salt, and pH=6.5-7.5; (2) Separation of crude glucogalactan: The fermentation liquid obtained in step (1) is centrifuged, the precipitate is discarded and the supernatant is collected, anhydrous ethanol is added to the supernatant, and the polysaccharide is precipitated by shaking, and the precipitate is recovered by filtration and dried to obtain a crude glucogalactan.

6. The production method according to claim 5, characterized in that In step (1), the shaking culture time is 36 to 72 hours; in step (2), the centrifugal speed is 5000 g , The centrifugation time is 30 min; the amount of anhydrous ethanol added is 2 to 3 times the volume of the supernatant, and the drying temperature is 50 to 75°C.

7. The method for purifying glucogalactan according to claim 4, characterized in that: The following steps are involved: (1) Dissolve the crude glucogalactan in water, centrifuge, discard the precipitate and collect the supernatant; (2) adding an equal volume of chloroform / n-butanol solvent to the supernatant obtained in step (1), wherein the volume ratio of chloroform to n-butanol is 4:1, shaking, centrifuging, and recovering the aqueous phase; (3) Repeat step (2) until the protein layer at the interface between the aqueous phase and the organic phase disappears, add anhydrous ethanol to the recovered aqueous phase, shake to precipitate the polysaccharide, filter and recover the precipitate, and dry to obtain pure glucosamine.

8. The purification method according to claim 7, characterized in that In step (1) or (2), the centrifugal speed is 5000g , The centrifugation time was 30 min.

9. The purification method according to claim 7, characterized in that In step (3), the amount of anhydrous ethanol added is 2 to 3 times the volume of the aqueous phase, and the drying temperature is 50 to 75°C.

10. Use of the glucogalactan according to claim 4 in preparing a drug for promoting skin wound healing.

Citation Information

Cited By

  • Multifunctional sweet clover rhizobium and application thereof

    CN120041330A